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Introduction 
The present strategy of vascular surgeons in the 
diagnosis and treatment of chronic critical limb 
ischaemia is based not only upon current clinical 
experience and research, as crystallised in the Euro- 
pean Consensus Document, I but also upon uncertain- 
ties: epidemiological factors, such as the risk profile 
and natural course of the disease, the prediction of 
imminent limb death, and the choice of the most 
suitable treatment. 
The Fontaine classification in combination with 
non-invasive blood pressure measurements, has 
formed the basis of the definition of critical limb 
ischaemia, as proposed by the European Consensus, 
but the solidity of this definition is criticised. 2'3 Other 
diagnostic tools are proposed to enhance discrimina- 
tion of the severity of the disease, including skin 
microcirculatory investigation, 4-6 the assessment of 
peripheral resistance in crural vessels peroperatively 7 
or by using pulse-generated run-off. 8'9 
Most of the patients with critical limb ischaemia 
need treatment for leg salvage, unless a primary 
amputation appears eligible. Percutaneous catheter 
and surgical interventions become increasingly 
aggressive, and the site of the bypass anastomosis 
reaches more and more distall~ °-12 while amputation 
of the limb is associated with a lower survival and 
quality of life. 13 Thus, more effort is to be dedicated to 
obtain information about the arterial outflow situa- 
tion. For this purpose, not only are Duplex ultrasound 
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scanning and digital substraction angiography used to 
visualise the proximal vessels, selective angiograph- 
ical visualisation of the crural arteries and plantar arch 
is also necessary 14"15 to assess whether or not the 
patient is operable, because should a distal tibial or 
foot artery be patent and an adequate autogenous vein 
available, distal arterial reconstruction can be per- 
formed with a high degree of success. 16 
When a patient is regarded as inoperable or 
surgical treatment has failed, which may amount in up 
to one-third of the patients having undergone vascular 
reconstruction, 1 non-surgical procedures, e.g. pharma- 
cotherapy 17"18 or spinal cord stimulation (SCS) 19'2° 
may be useful as an adjunctive or last-resort therapy. 
In spite of several publications reporting positive 
results, SCS is still a controversial therapy, mainly due 
to the absence of prospectively randomised trials. 
Jivegard et al. 21 are the first to publish a prospective 
randomised studyY At 18 months follow-up, limb 
salvage rates in the SCS and control groups were 62% 
and 45%, respectively. This indicative difference was 
not statistically significant, mainly due to the limited 
number of patients. The ongoing Dutch multi-centre 
randomised trial 22 is awaited for further knowledge as 
to the clinical impact and pathophysiological micro- 
circulatory effects. 
Drawing up an inventory of the strategies applied 
and problems encountered by vascular surgeons may 
be useful to assess the general thought about critical 
leg ischaemia nd the practical applicability of certain 
methods of diagnosis and therapy. In this paper an 
overview is presented of the results of the computer- 
interactive voting session held during the Satellite 
Symposium 'Spinal cord stimulation in critical limb 
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ischaemia' t the VII th Annual Meeting of the ESVS in 
Barcelona, 22 September, 1993, in which the opinions 
of 158 specialists in the field of vascular pathology 
concerning their personal experience, diagnostic and 
therapeutic approaches were gathered and combined. 
Thus, an attempt was made to assess the present 
strategy of the vascular specialist as to critical limb 
ischaemia. 
The symposium on SCS in non-reconstructable 
critical imb ischaemia was attended by 400 specialists. 
A computer-interactive voting system was installed in 
the lecture hall and 158 voting pads were connected to
the computer. Each pad had five buttons. Five papers 
were presented, iscussing the subject of critical imb 
ischaemia, including the results of bypass urgery and 
SCS. Following the presentations 23 multiple-choice 
questions were asked with five possible answers 
involving personal experience, diagnostic techniques, 
surgical procedures and non-surgical pproaches. By 
means of a computer-interactive voting system the 
answers of 158 randomly chosen attendees were 
collected. Some questions were cross-linked with 
others, providing additive information. The results of 
the interactive voting were expressed in percentages 
and bars. 
Results  
The majority of those present were vascular surgeons 
(82%) and general surgeons with special interest in 
vascular surgery (14%). Only 4% were angiologists. 
The geographical distribution of the audience is 
shown in Fig. 1. Of the total 77% were surgeons with 
more than 5 years of experience, 48% of them more 
than 10 years. 
The criteria of critical imb ischaemia ccording to 
Fig. 1. Geographical distribution f the vascular surgeons present. 
Table 1. Frequency (%) of the criteria chosen to define critical 
limb ischaemia. The question asked was: 'The European Consensus 
on critical limb ischaemia defines critical ischaemia as: ankle 
pressure < 50mmHg or toe pressure < 30mmHg. Which would you 
choose?' 
Ankle systolic pressure <50mmHg 55% 
Ankle systolic pressure <70mmHg 4% 
Toe systolic pressure < 30mmHg 28% 
Toe systolic pressure < 50mmHg 1% 
Microcirculatory parameters 12% 
the European Consensus ~ appears to be well-accepted 
(Table 1): 83% agreed on either an ankle pressure of 
< 50 mmHg or a toe pressure of < 30 mmHg. Only 4% 
voted for an ankle pressure borderline of 70 mmHg 
and 12% would prefer to add microcirculatory param- 
eters. Angiography is currently performed using 
either conventional selective angiography (31%) or 
intra-arterial DSA (62%). Translumbar aortography 
and intravenous DSA are rarely used. Regarding the 
preoperative non-invasive work-up in patients with 
critical eg ischaemia, 22% of the surgeons perform toe 
systolic blood pressure measurements in addition to 
ankle pressure measurements. Twenty-three per cent 
use Duplex ultrasonography to investigate the aortoi- 
liac segment, 9% apply transcutaneous oximetry, and 
8% measure the pulse-generated run-off. However, 
most surgeons (38%) only perform ankle pressure 
measurements as a preoperative work-up. 
The yearly numbers of arterial reconstructions 
performed by the surgeons' teams are shown in Fig. 2: 
more than 80% of the teams perform more than 100 
reconstructions per year. The individual annual score 
for infrapopliteal bypasses ranged from zero to more 
than 50, the majority (65%) being 10-50 a year. The 
final decision with regard to the treatment of critical 
ischaemia is taken by either the vascular surgeon 
himself (90%) or the vascular surgeon in the multi- 
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Fig. 2. Frequency histogram of the annual number of arterial 
reconstructions performed per surgical team. 
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Table 2. Frequency (%) of current solutions for artificial distal 
grafting. The question was: 'What do you do if you have to use an 
artificial graft (absence of vein) and you find a considerable 
mismatch with the recipient crural artery?' 
End-to-side anastomosis 28% 
Adjunctive arteriovenous fistula 6% 
Miller cuff 41% 
Linton patch 18% 
No surgery 7% 
Table 3. Frequency (%) of current solutions when only one crural 
artery, but no saphenous vein is available. The question was: 
'Imagine you consider the patient "reconstructable'. You have only 
one outflow crural artery but no vein available. What do you do?' 
Arm vein 36% 
PTFE graft 25% 
PTFE graft + adjunctive procedure 19% 
Vein allograft 13% 
No surgery 7% 
Table 4. Frequency (%) of the reasons for abstaining from 
reconstruction in patients with occluded superficial femoral and 
popliteal artery. The question was: 'When do you consider apatient 
with critical limb ischaemia and an occluded SFA and popliteal 
artery "non-reconstructable" ?' 
Only one patent crural outflow artery 6% 
Occlusion of all crural arteries, but patent foot artery 15% 
One patent crural artery, but absence of vein 9% 
One patent pedal artery, but absence of vein 31% 
Not without exploration of the vessel(s) 39% 
The most distal bypass performed by the sur- 
geons present was distal crural in 33% and pedal in 
45%. By cross-linking these results with the surgeons' 
experience, the distal grafts were applied by all 
surgeons, irrespective of their duration of practice, 
illustrating the aggressive policy of surgeons in 
general. In 99% the first choice of the conduit for an 
infrapopliteal bypass was autologous vein: 47% 
reversed and 52% in situ. In patients in whom a vein is 
absent and an artificial graft is needed, facing a 
considerable diameter mismatch with the recipient 
crural artery, a variety of solutions is chosen (Table 2): 
almost 70% of the surgeons would choose an adjunc- 
tive procedure, of which the Miller cuff 23 was the most 
popular. In patients who are elected for arterial 
reconstruction, but have only one crural outflow 
artery and no saphenous vein, the alternatives are 
listed in Table 3. The majority of the surgeons would 
search for an arm vein, a PTFE graft or a PTFE graft 
with an adjunctive procedure. A small percentage 
would refrain from surgery. 
When is a patient with an occluded superficial 
femoral and popliteal artery regarded as non-recon- 
structable? The general opinion obtained is shown in 
Table 4. Occlusion of the crural arteries means "non- 
reconstructable" to 15% of the surgeons. When no 
suitable vein is available, 40% of the surgeons abstain 
from reconstruction. Thirty-nine per cent of the 
surgeons will consider the patient reconstructable 
until the exploration of the crural and pedal vessels, 
indicating their zeal to perform an arterial 
reconstruction. 
During the session two angiograms were shown 
(Figs. 3, 4). The first shows contrast in the proximal 
call but without further outflow. When asked what 
kind of action the surgeons would take, the majority 
Fig. 3. Angiogram of the calf arteries. 
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said they would ask for a new and better angiogram 
before taking any decision. The second angiogram 
visualised clearly a pedal arch and distal outflow and 
the audience was asked whether they obtained com- 
parable results: 39% of the vascular surgeons stated 
they obtained similar angiograms, 47% a lower quality 
of X-ray. 
If a patient with critical limb ischaemia is con- 
sidered non-reconstructable, the treatments of choice 
besides analgesics are listed in Table 5. By cross- 
linking these results with the surgeons' geographical 
distribution, sympathectomy apparently is equally 
popular, but SCS is mainly performed in southern 
Europe (Fig. 5). Current experience with SCS is 
presented in Table 6, which shows that at least 48% 
have had some experience with SCS. After the 
symposium 22% of those present had become more 
sceptical about SCS. Twenty-five per cent of them had 
not changed their opinion. By contrast, 53% of the 
surgeons were more interested in SCS or would like to 
join a prospective study or would like to have more 
information. It has to be emphasised that all speakers 
presented their SCS experience in a rather self-critical 
approach, which possibly explained why 22% of the 
surgeons were more sceptical about SCS following the 
presentations. 
Reimbursement of SCS implantation is a problem 
in Europe: in 35% of the centres it is not reimbursed, 
most commonly in Northern and Western Europe. If 
the stimulator system is reimbursed, the money comes 
from the hospital budget (25%), national health care 
programme (15%) or private insurance (5%). In 20% of 
the centres the system is reimbursed in all patients. 
The indications proposed for SCS besides non- 
reconstructable r st pain and/or necrosis were Buer- 
gers disease (47%), reconstructable critical imb ischae- 
mia (18%), and intermittent claudication (2%). 
One-third of those present saw no other indication. 
Discussion 
Although the voting procedure was performed only 
by a subgroup of the specialists present during the 
symposium, there is little reason to believe that this 
would have caused any bias in the results due to 
different specialisations, since the vast majority of the 
participants were vascular surgeons, whose opinions 
were desired. There was no bias in geographical 
background. The audience consisted mainly of experi- 
enced vascular surgeons, who performed a high 
number of arterial reconstructions per team per year. 
This suggests a valuable amount of experience with 
critical limb ischaemia, in particular because more 
than 90% of the surgeons were responsible for the final 
decision as to the treatment of critical ischaemia. 
However, the audience was a selected one in that they 
were present at a scientific meeting, which may imply 
that they have come from university-affiliated or 
research-based centres in which more facilities are 
available for specialised surger~ as opposed to sur- 
geons working in non-academic or less-specialised 
Fig. 4. Angiogram of the foot arteries. 
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Table 5. Frequency (%) of treatment alternatives of non- 
reconstructable critical l imb ischaemia. The question was: 'If your 






Spinal cord stimulation 
Table 6. Frequency (%) of experience with spinal cord 
stimulation. Question: 'What was your experience with SCS before 
this symposium?' 
Never heard of it 3% 
16% No experience 18% 
24% No experience and sceptical 31% 
22% Limited experience 26% 
12% Extensive xperience 22% 
26% 
hospitals. It can therefore b  assumed that the audi- 
ence represented a proper sample for assessing pre- 
sent strategies regarding non-reconstructability. Sur- 
geons using SCS, however, might have been 
overrepresented, because of their interest in this 
subject, although more than 50% of the audience did 
not have experience with SCS. 
A vast majority (83%) agreed with the European 
consensus concerning the blood pressure cut-off val- 
ues in the definition of critical limb ischaemia. 
However, additive investigation, such as toe blood 
pressure and microcirculatory parameters, are fre- 
quently appreciated. This, combined with e aggres- 
sive diagnostic (pedal angiogram, exploration of distal 
vessels before a patient is found non-reconstructable) 
and surgical (femoropedal bypass) attitude illustrates 
the surgeon's urge to save the patients' ischaemic 
limbs. It might be accentuated that the number of 
surgeons performing crural (33%) and pedal (45%) 
grafts as their most distal bypass was surprisingly 
high. 
If a patient is found non-reconstructable, various 
alternative forms of therapy are in use, of which SCS is 
most frequently applied, despite the fact that the 
system is not paid for by most hospitals or countries. 
Again, we emphasise that the audience may have been 
overrepresented by vascular surgeons with special 
interest in SCS. Results of ongoing studies of the 
effects of SCS will hopefully smooth e reimburse- 
ment procedures. 
The key issue is when to consider a patient non- 
60 0040° a a  >la  
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Geographical distribution 
Fig. 5. Cross-link between the therapy for non-reconstructable 
critical imb ischaemia preferred by the surgeon and geographical 
location. ([]) amputation, ([]) sympathectom~5 ([~) vaso-active 
drugs, ([]) analgesics, (ll) SCS. 
reconstructable. Apart from absence of vein, the 
decision mainly depends on the presence of a crural 'or 
pedal vessel. It is therefore mandatory that selective 
angiograms visualising crural and pedal vessels are 
available to evaluate whether apatient's vasculature is 
truly unreconstructable. The fact that a considerable 
number of surgeons did not get optimal angiograms 
underlines the further need for this optimal assess- 
ment in the decision of how to treat the patient with 
critical imb ischaemia. 
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